Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42796282

Ahmet Melih Arslan; Ahmet Ünsal; Faruk Recep Özalp; Gülhan Dinç; Hüseyin Salih Semiz; Mehmet Türker; Mehmet Uzun; Mustafa Erman; Mustafa Seyyar; Nadiye Sever; Nargiz Majidova Altunta?; Sedat Biter; Umut Kefeli

Sep 27, 2026